Barclays’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-105
| Closed | – | – | 4567 |
|
|
2018
Q1 | $0 | Buy |
105
+102
| +3,400% | – | ﹤0.01% | 4548 |
|
|
2017
Q4 | $0 | Sell |
3
-48
| -94% | – | ﹤0.01% | 4302 |
|
|
2017
Q3 | $0 | Buy |
51
+48
| +1,600% | – | ﹤0.01% | 4255 |
|
|
2017
Q2 | $0 | Sell |
3
-3,991
| -100% | – | ﹤0.01% | 4254 |
|
|
2017
Q1 | $14K | Buy |
3,994
+3,827
| +2,292% | +$13.4K | ﹤0.01% | 3461 |
|
|
2016
Q4 | $0 | Buy |
167
+136
| +439% | – | ﹤0.01% | 4123 |
|
|
2016
Q3 | $1K | Sell |
31
-38
| -55% | -$1.23K | ﹤0.01% | 3874 |
|
|
2016
Q2 | $2K | Sell |
69
-2,238
| -97% | -$64.9K | ﹤0.01% | 3342 |
|
|
2016
Q1 | $55K | Buy |
2,307
+593
| +35% | +$14.1K | ﹤0.01% | 2498 |
|
|
2015
Q4 | $55K | Buy |
1,714
+438
| +34% | +$14.1K | ﹤0.01% | 2460 |
|
|
2015
Q3 | $61K | Buy |
1,276
+1,190
| +1,384% | +$56.9K | ﹤0.01% | 2532 |
|
|
2015
Q2 | $5K | Buy |
+86
| New | +$5K | ﹤0.01% | 3652 |
|